ストックスクリーナーアプリを入手
77.78
0.71%
0.795
前日終値:
$76.98
開ける：
$76.92
24時間の取引高:
102.74K
Relative Volume:
0.17
時価総額：
$3.30B
収益：
$17.39M
当期純損益:
$-135.89M
株価収益率:
-16.76
EPS:
-4.64
ネットキャッシュフロー:
$-123.00M
1週間 パフォーマンス:
+6.32%
1か月 パフォーマンス:
+9.47%
6か月 パフォーマンス:
+79.51%
1年 パフォーマンス:
+67.09%
1日の値動き範囲:
$73.86
$78.10
1週間の範囲:
$72.80
$82.42
52週間の値動き範囲:
$38.51
$82.42
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
名前
Tarsus Pharmaceuticals Inc
セクター
電話
(949) 409-9820
住所
15440 LAGUNA CANYON ROAD, IRVINE
TARS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
77.81 | 3.27B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.34 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
747.89 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.80 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
919.59 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.60 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-20 | 開始されました | Mizuho | Outperform |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2025-05-27 | 再開されました | H.C. Wainwright | Buy |
| 2023-11-20 | 開始されました | Goldman | Neutral |
| 2023-07-18 | 開始されました | William Blair | Outperform |
| 2023-05-18 | 開始されました | Guggenheim | Buy |
| 2022-08-01 | 開始されました | Barclays | Overweight |
| 2021-12-21 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-23 | 開始されました | Oppenheimer | Outperform |
| 2020-11-10 | 開始されました | BofA Securities | Buy |
| 2020-11-10 | 開始されました | Jefferies | Buy |
| 2020-11-10 | 開始されました | Ladenburg Thalmann | Buy |
| 2020-11-10 | 開始されました | Raymond James | Strong Buy |
すべてを表示
Tarsus Pharmaceuticals Inc (TARS) 最新ニュース
Will Tarsus Pharmaceuticals Inc. stock maintain dividend yieldMarket Trend Summary & Fast Gain Swing Alerts - newser.com
Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 (NASDAQ:TARS) - Seeking Alpha
Mizuho Initiates Coverage on Tarsus Pharmaceuticals (TARS) with Outperform Rating | TARS Stock News - GuruFocus
Mizuho initiates coverage on Tarsus Pharmaceuticals stock with Outperform rating - Investing.com Canada
Mizuho Initiates Tarsus Pharmaceuticals at Outperform With $100 Price Target - MarketScreener
Will Tarsus Pharmaceuticals Inc. stock remain a Wall Street favoriteWeekly Stock Recap & Daily Oversold Bounce Ideas - newser.com
Price-Driven Insight from (TARS) for Rule-Based Strategy - news.stocktradersdaily.com
Will Tarsus Pharmaceuticals Inc. stock outperform Nasdaq indexJuly 2025 Spike Watch & Growth Focused Stock Reports - newser.com
What catalysts could drive Tarsus Pharmaceuticals Inc. stock higherMarket Movement Recap & Daily Oversold Stock Bounce Ideas - newser.com
Is Tarsus Pharmaceuticals Inc. stock poised for growth2025 Stock Rankings & Daily Entry Point Trade Alerts - newser.com
Can Tarsus Pharmaceuticals Inc. stock resist market sell offs2025 Retail Activity & Real-Time Price Movement Reports - newser.com
Long term hold vs stop loss in Tarsus Pharmaceuticals Inc.Market Performance Summary & Fast Entry Momentum Alerts - newser.com
Midday Stock Roundup: Eledon Falls after Trial Report - Orange County Business Journal
Tarsus Pharmaceuticals stock hits all-time high at 76.85 USD By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals stock hits all-time high at 76.85 USD - Investing.com
Full technical analysis of Tarsus Pharmaceuticals Inc. stockJuly 2025 Highlights & Low Risk Investment Opportunities - newser.com
Can Tarsus Pharmaceuticals Inc. stock sustain market leadershipJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com
OC500 2025: BOBAK “BOBBY” AZAMIAN - Orange County Business Journal
What momentum indicators show for Tarsus Pharmaceuticals Inc. stockJuly 2025 Pullbacks & High Conviction Buy Zone Alerts - newser.com
Does Tarsus Pharmaceuticals Inc. fit your quant trading modelJuly 2025 News Drivers & Expert Verified Stock Movement Alerts - newser.com
Top chart patterns to watch in Tarsus Pharmaceuticals Inc.July 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Tarsus Pharmaceuticals Inc (TARS) 財務データ
収益
当期純利益
現金流量
EPS
1.07%
1.18%
大文字化:
|
ボリューム (24 時間):